The study involved 323 people who had no memory problems when first tested but later developed dementia. Memory tests and physical exams were then given every 18 months.
The study found that after an Alzheimer’s diagnosis was made, people with diabetes were twice as likely to die sooner than those without diabetes who had Alzheimer’s disease. People with Alzheimer’s disease who had high blood pressure were two-and-a-half times more like to die sooner than those with normal blood pressure.
“Studies show that the average lifespan of a person diagnosed with Alzheimer’s can be anywhere from three to nine years. For that person and their caregiver, every minute counts. Here we have two controllable factors that may drastically affect how long that person can survive,” said study author Yaakov Stern, PhD, professor at the Taub Institute for Research on Alzheimer’s Disease and the Aging Brain and director of the Cognitive Neuroscience Division of Gertrude H. Sergievsky Center at Columbia University Medical Center in New York. Stern is also a member of the American Academy of Neurology.
The study also looked at how race could affect how long a person lives with Alzheimer’s disease. It found Hispanic people lived for eight years after diagnosis, about four years longer than non-Hispanic white people did. African-Americans lived an average of five years, longer than non-Hispanic whites but not as long as Hispanic people. However, after adjusting for gender and other factors, the results were no longer significant.
“Though these findings were not significant, they are intriguing and warrant further research as to whether race affects survival time in people with Alzheimer’s disease,” said Stern.
The study was supported by the National Institute on Aging.
The American Academy of Neurology, an association of more than 21,000 neurologists and neuroscience professionals, is dedicated to improving patient care through education and research. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as epilepsy, dystonia, migraine, Huntington’s disease, and dementia.
Angela Babb | American Academy of Neurology
Research offers clues for improved influenza vaccine design
09.04.2018 | NIH/National Institute of Allergy and Infectious Diseases
Injecting gene cocktail into mouse pancreas leads to humanlike tumors
06.04.2018 | University of Texas Health Science Center at San Antonio
Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.
Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...
Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.
The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...
Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.
Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...
In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...
In an article that appears in the journal “Review of Modern Physics”, researchers at the Laboratory for Attosecond Physics (LAP) assess the current state of the field of ultrafast physics and consider its implications for future technologies.
Physicists can now control light in both time and space with hitherto unimagined precision. This is particularly true for the ability to generate ultrashort...
13.04.2018 | Event News
12.04.2018 | Event News
09.04.2018 | Event News
19.04.2018 | Materials Sciences
19.04.2018 | Physics and Astronomy
19.04.2018 | Physics and Astronomy